Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network

AIM: To describe baseline characteristics and follow‐up data in patients with lipodystrophy syndromes treated with metreleptin in a national reference network, in a real‐life setting. PATIENTS AND METHODS: Clinical and metabolic data from patients receiving metreleptin in France were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosbah, Héléna, Vantyghem, Marie‐Christine, Nobécourt, Estelle, Andreelli, Fabrizio, Archambeaud, Francoise, Bismuth, Elise, Briet, Claire, Cartigny, Maryse, Chevalier, Benjamin, Donadille, Bruno, Daguenel, Anne, Fichet, Mathilde, Gautier, Jean‐François, Janmaat, Sonja, Jéru, Isabelle, Legagneur, Carole, Leguier, Lysiane, Maitre, Julie, Mongeois, Elise, Poitou, Christine, Renard, Eric, Reznik, Yves, Spiteri, Anne, Travert, Florence, Vergès, Bruno, Zammouri, Jamila, Vigouroux, Corinne, Vatier, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541305/
https://www.ncbi.nlm.nih.gov/pubmed/35445532
http://dx.doi.org/10.1111/dom.14726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541305/
https://www.ncbi.nlm.nih.gov/pubmed/35445532
http://dx.doi.org/10.1111/dom.14726

Ejemplares similares